Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Cantor Fitzgerald
Cipla
US Department of Justice
Deloitte

Generated: August 24, 2019

DrugPatentWatch Database Preview

Litigation for Patent 7,476,652

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Court Litigation for Patent: 7,476,652

Patent Trial and Appeal Board Cases for Patent 7,476,652

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
7,476,652 Mylan Pharmaceuticals Inc., ➤ Sign Up 2017-06-05 2017-06-05 Brunner-Schwarz et al Inter partes review ➤ Sign Up 2017-12-13 ➤ Sign Up
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Covington
Fuji
McKesson
Merck
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.